Correlation Between MediciNova and Zura Bio
Can any of the company-specific risk be diversified away by investing in both MediciNova and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Zura Bio Limited, you can compare the effects of market volatilities on MediciNova and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Zura Bio.
Diversification Opportunities for MediciNova and Zura Bio
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between MediciNova and Zura is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of MediciNova i.e., MediciNova and Zura Bio go up and down completely randomly.
Pair Corralation between MediciNova and Zura Bio
Given the investment horizon of 90 days MediciNova is expected to generate 0.63 times more return on investment than Zura Bio. However, MediciNova is 1.59 times less risky than Zura Bio. It trades about -0.05 of its potential returns per unit of risk. Zura Bio Limited is currently generating about -0.23 per unit of risk. If you would invest 201.00 in MediciNova on November 27, 2024 and sell it today you would lose (27.00) from holding MediciNova or give up 13.43% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
MediciNova vs. Zura Bio Limited
Performance |
Timeline |
MediciNova |
Zura Bio Limited |
MediciNova and Zura Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MediciNova and Zura Bio
The main advantage of trading using opposite MediciNova and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
Zura Bio vs. CVR Partners LP | Zura Bio vs. Highway Holdings Limited | Zura Bio vs. Sensient Technologies | Zura Bio vs. Griffon |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |